Adaptive Biotechnologies Corp (ADPT NASDAQ) stock market data APIs
$13.752
0.95(6.9%)
as of May 5, 2026
Try our APIs with
free plan!
Adaptive Biotechnologies Corp Financial Data Overview
Price chart is built with
Anychart
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Prev. Close
13.752
Open
14.7022
High
14.8693
Low
13.6324
52 wk Range
8.5-20.76
Market Cap
2 202 M
Shares Outstanding
160 M
Revenue
277 M
EPS
-0.13
Beta
2.163
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Adaptive Biotechnologies Corp (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Adaptive Biotechnologies Corp data using free add-ons & libraries
Get Adaptive Biotechnologies Corp Fundamental Data
Adaptive Biotechnologies Corp Fundamental data includes:
- Net Revenue: 277 M
- EBITDA: -39 290 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Adaptive Biotechnologies Corp Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-06
- EPS/Forecast: -0.1746
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Adaptive Biotechnologies Corp News
New
Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Adaptive Biotechnologies (ADPT) reported $70.87 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 35.2%. EPS of -$0.13 for the same period compares to -$0....
Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Beats Revenue Estimates
Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.2 per share a year ago. These fi...
Adaptive Biotechnologies Reports First Quarter 2026 Financial Results
Adaptive Biotechnologies SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that ...
How The Investment Story For Adaptive Biotechnologies (ADPT) Is Shifting With New Street Assumptions
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Adaptive Biotechnologies is back in focus after a fresh look at its valuation n...
Get Adaptive Biotechnologies Corp fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
